Electrocardiogram in Fabry's disease;Elektrokardiogram w chorobie Fabry'ego

Kardiologia Polska

Volumn 66, Issue 6, 2008, Pages 688-692

  Jastrzȩbski, Marek ^a   Petkow Dimitrow, Paweł ^b  

^a UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRADYCARDIA; CARDIOMYOPATHY; ELECTROCARDIOGRAM; FABRY DISEASE;

EID: 53549128148     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Suzuki M, Goto T, Kato R, et al. Combined atrioventricular block and sinus node dysfunction in Fabry's disease. Am Heart J 1990; 120: 438-40.
2. Sheth KJ, Thomas JP Jr. Electrocardiograms in Fabry's disease. J Electrocardiol 1982; 15: 153-6.
3. Hoigné P, Attenhofer Jost CH, Duru F, et al. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy. Int J Cardiol 2006; 111: 413-22.
4. Kampmann C, Wiethoff CM, Martin C, et al. Electrocardiographic signs of hypertrophy in Fabry disease-associated hypertrophic cardiomyopathy. Acta Paediatr Suppl 2002; 91: 21-7.
5. Bazan-Socha S, Miszalski-Jamka T, Petkow-Dimitrow P, et al. Clinical stability of Fabry disease in 54 months' enzyme placement therapy - follow-up of the first Polish study. Pol Arch Med Wewn 2007; 117: 260-5.
6. Jastrzebski M, Bacior B, Dimitrow PP, et al. Electrophysiological study in a patient with Fabry disease and a short PQ interval. Europace 2006; 8: 1045-7.
7. Pochis WT, Litzow JT, King BG, et al. Electrophysiologic findings in Fabry's disease with a short PR interval. Am J Cardiol 1994; 74: 203-4.
8. Gillette PC, Nihill MR, Singer DB. Electrophysiological mechanism of the short PR interval in Pompe disease. Am J Dis Child 1974; 128: 622-6.
9. Marras E, Sciarra L, Bocchino M, et al. Pacemaker malfunctions in Danon's disease. Pacing Clin Electrophysiol 2008; 31: 125-8.
10. Jastrzebski M. An excellent review about inherited conduction system abnormalities. J Cardiovasc Electrophysiol 2006; 17: E5.
11. Linhart A, Lubanda JC, Palecek T, et al. Cardiac manifestations in Fabry disease. J Inherit Metab Dis 2001; 24: 75-83.
12. Mehta J, Tuna N, Moller JH, et al. Electrocardiographic and vectorcardiographic abnormalities in Fabry's disease. Am Heart J 1977; 93: 699-705.
13. Waldek S. PR interval and the response to enzyme-replacement therapy for Fabry's disease. N Engl J Med 2003; 348: 1186-7.
14. Kouris NT, Kontogianni DD, Pavlou MT, et al. Atrioventricular conduction disturbances in a young patient with Fabry's disease without other signs of cardiac involvement. Int J Cardiol 2005; 99: 327-8.
15. Brignole M, Gaggioli G, Menozzi C, et al. Adenosine-induced atrioventricular block in patients with unexplained syncope: the diagnostic value of ATP testing. Circulation 1997; 96: 3921-7.